Factors Influencing Self-Reported Use of Antioxidant Supplements in Patients with Age-Related Macular Degeneration
Authors:
- Tobias PaulTPTobias Paul
- Markus SchaumbergerMSMarkus Schaumberger
- Ulrich Welge-LussenUWUlrich Welge-Lussen
- 21 April 2014
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 39 (12) , 1240-1246
Abstract
The goals of the present study were to evaluate the current use and accuracy of dose-taking prescription among patients with age-related macular degeneration (AMD) and to detect potential factors influencing the use or non-use of oral antioxidant supplements. This is a cross-sectional questionnaire-based study of 65 patients with AMD of Age-Related Eye Disease Study (AREDS) category 3 (intermediate AMD) or category 4 (unilateral advanced AMD). Self-report data were obtained from a structural clinical interview in clinic. The patients were asked questions regarding their demographic, ophthalmologic and systemic data, their source of recommendation for antioxidant supplement use and/or their reasons for non-use. Afterwards, this information was correlated with the use or non-use of antioxidant supplements. Statistical analyses were conducted using a series of Mann-Whitney U-tests and Fisher's exact tests. There were 55.4% (36 of 65) of the patients reporting antioxidant supplement use for AMD and 44.6% (29 of 65) with no supplement use. However, only 56.7% (17 of 30) took the recommended dose on label. There were significantly more female patients taking supplements than male patients (p = 0.010). A statistically significant correlation was also found between supplement use and the number of visits to an ophthalmologist per year (p = 0.037). The main reason for antioxidant supplement non-use was the missing awareness of the availability of antioxidant supplements. Despite the recommendation of oral antioxidant supplements in the ARED Study for patients with AMD of category 3 or 4, only about half of these patients took the supplements in this study. Identifying the factors, which influenced the decision against supplement use, may help to better support patients in the prevention of severe vision loss caused by AMD.Keywords
This publication has 19 references indexed in Scilit:
- Patient Characteristics Associated with Medication AdherenceClinical Medicine & Research, 2013
- ADHERENCE TO RECOMMENDATIONS OF THE AGE-RELATED EYE DISEASE STUDY IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATIONRetina, 2010
- An Exploratory Study of Factors Influencing Glaucoma Treatment AdherenceJournal of Glaucoma, 2010
- Risk Factors for Poor Adherence to Eyedrops in Electronically Monitored Patients with GlaucomaOphthalmology, 2009
- Vitamin Usage Patterns in the Prevention of Advanced Age-Related Macular DegenerationOphthalmology, 2008
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Awareness of and compliance with recommended dietary supplement among age‐related macular degeneration patientsClinical & Experimental Ophthalmology, 2006
- AREDS—Two Years LaterArchives of Ophthalmology (1950), 2003
- Retinal Arteriolar Narrowing and Risk of Diabetes Mellitus in Middle-aged PersonsArchives of Ophthalmology (1950), 2003
- Prevalence of Age-related MaculopathyOphthalmology, 1992